Overview

The Effect of GCSF in the Treatment of ALS Patients

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effect off Granulocyte Colony Stimulating Factor (GCSF) in the treatment of Amyotrophic Lateral Sclerosis (ALS) patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tehran University of Medical Sciences
Treatments:
Lenograstim
Sargramostim